5 Takeaways From FBI Director Kash Patel’s Senate Testimony
FBI Director Kash Patel testified during what was at times a tense hearing on Capitol Hill on Sept. 16. During the Senate Judiciary Committee...
All News
Left-Wing Groups Face Probes in Wake of Charlie Kirk Assassination
WASHINGTON—The assassination of conservative commentator Charlie Kirk has touched off wider efforts to investigate individuals and organizations on the far left. As Trump administration...
Lawmakers Ask Treasury Department to Probe China-Based Billionaire Over Alleged Ties to ‘Far-Left Entities’
Two House Oversight Republicans are urging the Treasury Department to formally investigate a China-based billionaire as part of a broader investigation into the Chinese...
Democrats Press for Bipartisan Spending Bill With a Focus on Health Care
House Democratic leaders on Tuesday pressed for bipartisan negotiations on a government funding bill, saying that Republican proposals could drive up healthcare costs and...
Rubio Says US Visa Revocations Underway After Charlie Kirk Death Celebrations
Secretary of State Marco Rubio said that foreign nationals who made celebratory comments over Charlie Kirk’s assassination will have their U.S. visas revoked, adding...
‘Zombie juice’: Japan battles rise of dangerous club drug sweeping Asia
A night out in Okinawa ended in an ambulance ride for one young woman, her body unresponsive after a single puff from an e-cigarette....
Fake Charlie Kirk shooter George Zinn arrested for child porn
George Zinn, the Utah man who falsely confessed to killing Charlie Kirk moments after last week’s fateful shooting at Utah Valley University, now stands...
Lidar maker Hesai to pour Hong Kong listing proceeds into expanding production
Hesai Group, the world’s largest maker of automotive lidar sensors, plans to double down on production capacity amid a bullish global outlook for intelligent...
Chinese biotech start-up challenging US dominance aims for IPO in 2027
Shuimu BioSciences, a Chinese start-up specialising in advanced imaging devices for viruses and smaller biomolecules, is aiming for an initial public offering in 2027...